Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate added to aripiprazole in pediatric bipolar disorder: metabolic effects trial
IRCT20200606047668N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of topiramate and aripiprazole in bipolar disorder (BD) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Metabolic indices and Severity of bipolar disorder. Started Jun 2020; status: completed.
02
Drugs
topiramatearipiprazole
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20200606047668N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200606047668N1.